Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days

• Mykola Pinkevych,

  Affiliation Kirby Institute for Infection and Immunity, UNSW Australia, Sydney, Australia

  ⨯
• Stephen J. Kent,

  Affiliations Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australia, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia, Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia

  ⨯
• Martin Tolstrup,

  Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Sharon R. Lewin,

  Affiliations The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia, Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia

  ⨯
• David A. Cooper,

  Affiliation Kirby Institute for Infection and Immunity, UNSW Australia, Sydney, Australia

  ⨯
• Ole S. Søgaard,

  Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Thomas A. Rasmussen,

  Affiliations The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia, Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Anthony D. Kelleher,

  Affiliation Kirby Institute for Infection and Immunity, UNSW Australia, Sydney, Australia

  ⨯
• Deborah Cromer,

  Affiliation Kirby Institute for Infection and Immunity, UNSW Australia, Sydney, Australia

  ⨯
• Miles P. Davenport

  * E-mail: M.davenport@unsw.edu.au

  Affiliation Kirby Institute for Infection and Immunity, UNSW Australia, Sydney, Australia

  ⨯